Beam Therapeutics Inc. (BEAM)
Market Closed
16 Oct, 08:00 PM
NASDAQ (NGS) NASDAQ (NGS) Primary 
XMEX $
23. 47
-1.26
-5.095%
$
2.64B Market Cap
- P/E Ratio
- Div Yield
1.65M Volume
-5.38 Eps
$ 24.73
Previous Close 
Want to track BEAM and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Beam Therapeutics Inc. (BEAM) Statistics
Valuation metrics
Market Cap 2.64B
Enterprise value 2.67B
Trailing P/E (ttm) -31.34
Forward P/E -
PEG ratio -0.42
Price/Sales (ttm) 16.94
Price/Book (mrq) 2.51
Enterprise Value/Revenue 17.12
Enterprise Value/EBITDA -42.28
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 1.8M
Average volume (90 days) 2.61M
Price summary
52-Week low 20.23
52-Week high 38.26
Beta -
50-Day moving average 26.27
200-Day moving average 28.32
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -0.55%
Operating margin -2.42%
Operational effectiveness
Return on assets -0.06%
Return on equity -0.08%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 1.5
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.82
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 11.05
Total debt (mrq) -
Total Debt/Equity (mrq) 0.23
Current ratio (mrq) 14.57%
Book value per share (mrq) 10.23
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
